Multimodal Treatment for Head and Neck Cancer

Surgical Clinics of North America

Volumn 89, Issue 1, 2009, Pages 43-52

  Lango, Miriam N ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Head and neck squamous carcinoma; Multimodal treatment; Organ preservation; Radiation

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DRUG MEGADOSE; DYSPHAGIA; EAR NOSE THROAT SURGERY; GLOSSECTOMY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX CANCER; LASER SURGERY; MANDIBLE RESECTION; MINIMALLY INVASIVE SURGERY; MOUTH CANCER; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; ORGAN PRESERVATION; OROPHARYNX CANCER; OROPHARYNX TUMOR; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; ROBOTICS; SPEECH; SQUAMOUS CELL CARCINOMA; STOMACH TUBE; SWALLOWING; SYSTEMIC THERAPY; TONGUE CANCER; TRACHEOTOMY; TREATMENT OUTCOME; TUMOR LOCALIZATION; WART VIRUS; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; GASTROSTOMY; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; OROPHARYNGEAL NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 58749104427     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.09.018     Document Type: Review

References (47)

1. Sturgis E.M., and Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 110 7 (2007) 1429-1435
2. Ernster J.A., Sciotto C.G., O'Brien M.M., et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117 12 (2007) 2115-2128
3. Spiro R.H., Huvos A.G., Wong G.Y., et al. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 152 4 (1986) 345-350
4. Sparano A., Weinstein G., Chalian A., et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 131 4 (2004) 472-476
5. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350 19 (2004) 1937-1944
6. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 19 (2004) 1945-1952
7. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27 10 (2005) 843-850
8. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 4 (1992) 231-241
9. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 9538 (2006) 843-854
10. Parsons J.T., Mendenhall W.M., Cassisi N.J., et al. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 14 4 (1988) 649-658
11. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 25 (1998) 1798-1804
12. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 4 (2000) 876-883
13. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 22 (2003) 2091-2098
14. Machtay M., Rosenthal D.I., Hershock D., et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 20 19 (2002) 3964-3971
15. Vokes E.E., Stenson K., Rosen F.R., et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21 2 (2003) 320-326
16. Liauw S.L., Mancuso A.A., Amdur R.J., et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24 9 (2006) 1421-1427
17. Yom S.S., Machtay M., Biel M.A., et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 28 4 (2005) 385-392
18. Temam S., Pape E., Janot F., et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 62 4 (2005) 1078-1083
19. Bourhis J., Lapeyre M., Tortochaux J., et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 24 18 (2006) 2873-2878
20. Weber R.S., Berkey B.A., Forastiere A., et al. Outcome of salvage total laryngectomy following organ preservation therapy: the radiation therapy oncology group trial 91-11. Arch Otolaryngol Head Neck Surg 129 1 (2003) 44-49
21. Goodwin Jr. W.J. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?. Laryngoscope 110 3 Pt 2 Suppl 93 (2000) 1-18
22. Trotti A., Pajak T.F., Gwede C.K., et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8 7 (2007) 613-624
23. de Castro Jr. G., Snitcovsky I.M., Gebrim E.M., et al. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, nonmetastatic stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 264 12 (2007) 1475-1482
24. Pacholke H.D., Amdur R.J., Morris C.G., et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 28 4 (2005) 351-358
25. Langerman A., Maccracken E., Kasza K., et al. Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133 12 (2007) 1289-1295
26. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68 5 (2007) 1289-1298
27. Shiboski C.H., Schmidt B.L., and Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 103 9 (2005) 1843-1849
28. Dahlstrand H, Lindquist W, Ye T, et al. Human papillomavirus (HPV) as a risk factor for the increase in incidence of tonsillar cancer and its expression of E6 and E7. Presented at: ASCO Annual Meeting Proceedings. Chicago, May 30-June 3 2008, 2008.
29. Carvalho A.L., Nishimoto I.N., Califano J.A., et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114 5 (2005) 806-816
30. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 4 (2008) 261-269
31. Agrawal A., Moon J., Davis R.K., et al. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group phase 2 trial S9709. Arch Otolaryngol Head Neck Surg 133 10 (2007) 1044-1050
32. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324 24 (1991) 1685-1690
33. Lefebvre J.L., Chevalier D., Luboinski B., et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88 13 (1996) 890-899
34. Laccourreye H., Laccourreye O., Weinstein G., et al. Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 100 7 (1990) 735-741
35. Laccourreye H., Laccourreye O., Weinstein G., et al. Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma. Ann Otol Rhinol Laryngol 99 6 Pt 1 (1990) 421-426
36. Dufour X., Hans S., De Mones E., et al. Local control after supracricoid partial laryngectomy for advanced endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 130 9 (2004) 1092-1099
37. Deganello A., Gallo O., De Cesare J.M., et al. Supracricoid partial laryngectomy as salvage surgery for radiation therapy failure. Head Neck 30 8 (2008) 1064-1071
38. Marioni G., Marchese-Ragona R., Lucioni M., et al. Organ-preservation surgery following failed radiotherapy for laryngeal cancer. Evaluation, patient selection, functional outcome, and survival. Curr Opin Otolaryngol Head Neck Surg 16 2 (2008) 141-146
39. Strong M.S., and Jako G.J. Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 81 6 (1972) 791-798
40. Steiner W., Ambrosch P., Hess C.F., et al. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 124 1 (2001) 58-67
41. Steiner W., Fierek O., Ambrosch P., et al. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129 1 (2003) 36-43
42. Ambrosch P., Kron M., and Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107 8 (1998) 680-688
43. Weinstein G.S., O'Malley Jr. B.W., Snyder W., et al. Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116 1 (2007) 19-23
44. Weinstein G.S., O'Malley Jr. B.W., Snyder W., et al. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133 12 (2007) 1220-1226
45. O'Malley Jr. B.W., Weinstein G.S., Snyder W., et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116 8 (2006) 1465-1472
46. Holsinger F.C., Prichard C.N., Shapira G., et al. Use of the photonic band gap fiber assembly CO2 laser system in head and neck surgical oncology. Laryngoscope 116 7 (2006) 1288-1290
47. Higgins K.M., and Wang J.R. State of head and neck surgical oncology research-a review and critical appraisal of landmark studies. Head Neck 30 (2008) 1636-1642